Cocaine Use Disorder Market Outlook to Strengthen During the Forecast Period (2026-2036) with Emerging Therapies and Rising Healthcare Needs | DelveInsight
The cocaine use disorder market is expected to be driven by the anticipated introduction of emerging therapies including Mavoglurant (STP7; STALICLA), Metyrapone (EMB-001; Embera NeuroTherapeutics), TMP-301 (Tempero Bio), OMS527 (Omeros Corporation), AT-312 (Astraea Therapeutics), and...
Covered in this story
Call it yourself
No calls on $TMP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tompkins Financial Corp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.